MTX-101 (MetasTx)

N/A

Report date: 2026/04/08 15:32:57
NME

Base Information

Drug NameMTX-101 (MetasTx)
Drug Alias NamePAK-1 protein kinase inhibitor (MetasTx)
ClassificationSmall molecules
Mechanisms of ActionSerine/threonine-protein kinase PAK 1 inhibitors
TargetsSerine/threonine-protein kinase PAK 1
Therapy Area/IndicationsNeoplasm MetastasisProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMetasTx LLC
China Registration ClassN/A

Develop Information

Active CompaniesMetasTx LLC
Inactive CompaniesN/A
Active IndicationsNeoplasm MetastasisProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A